Literature DB >> 16636091

Mechanisms and measurement of dyspnea in chronic obstructive pulmonary disease.

Donald A Mahler1.   

Abstract

Patients with chronic obstructive pulmonary disease (COPD) describe their breathlessness as related to the work and effort associated with breathing. Current evidence suggests that the perception of dyspnea is due to a "mismatch" between the outgoing motor command from the central nervous system and the corresponding afferent information from chemoreceptors and/or mechanoreceptors. To measure the severity of dyspnea the principles of psychophysics (stimulus --> response relationship) can be applied. One approach is to consider activities of daily living as a putative stimulus. Although this method relies on patient recall and description of daily tasks, ability to function, as well as time and effort to complete an activity, select clinical instruments have demonstrated appropriate measurement criteria in randomized clinical trials involving patients with COPD. Another approach is for a patient to report the intensity of dyspnea during exercise, and current practice is to provide ratings each minute "on cue" during the exercise test. A computerized system has been developed whereby the person can report ratings spontaneously and continuously by moving a computer mouse that adjusts a vertical bar adjacent to 0-10 category-ratio scale positioned on a monitor. With this continuous method the patient reports twice the number of dyspnea ratings during exercise compared with discrete ratings each minute. Patient-reported dyspnea based on activities of daily living and exercise testing provides distinct but complimentary information.

Entities:  

Mesh:

Year:  2006        PMID: 16636091     DOI: 10.1513/pats.200509-103SF

Source DB:  PubMed          Journal:  Proc Am Thorac Soc        ISSN: 1546-3222


  10 in total

1.  Chronic obstructive pulmonary disease in China: the potential role of indacaterol.

Authors:  Jinming Gao; Niyati Prasad
Journal:  J Thorac Dis       Date:  2013-08       Impact factor: 2.895

2.  The longitudinal pattern of response when morphine is used to treat chronic refractory dyspnea.

Authors:  David C Currow; Stephen Quinn; Aine Greene; Janet Bull; Miriam J Johnson; Amy P Abernethy
Journal:  J Palliat Med       Date:  2013-06-08       Impact factor: 2.947

3.  Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease.

Authors:  Donald P Tashkin; Robert Elashoff; Philip J Clements; Michael D Roth; Daniel E Furst; Richard M Silver; Jonathan Goldin; Edgar Arriola; Charlie Strange; Marcy B Bolster; James R Seibold; David J Riley; Vivien M Hsu; John Varga; Dean Schraufnagel; Arthur Theodore; Robert Simms; Robert Wise; Fred Wigley; Barbara White; Virginia Steen; Charles Read; Maureen Mayes; Ed Parsley; Kamal Mubarak; M Kari Connolly; Jeffrey Golden; Mitchell Olman; Barri Fessler; Naomi Rothfield; Mark Metersky; Dinesh Khanna; Ning Li; Gang Li
Journal:  Am J Respir Crit Care Med       Date:  2007-08-23       Impact factor: 21.405

4.  Dyspnea severity, changes in dyspnea status and mortality in the general population: the Vlagtwedde/Vlaardingen study.

Authors:  Sylwia M Figarska; H Marike Boezen; Judith M Vonk
Journal:  Eur J Epidemiol       Date:  2012-10-07       Impact factor: 8.082

5.  Lung function efficacy and symptomatic benefit of olodaterol once daily delivered via Respimat® versus placebo and formoterol twice daily in patients with GOLD 2-4 COPD: results from two replicate 48-week studies.

Authors:  Andrea Koch; Emilio Pizzichini; Alan Hamilton; Lorna Hart; Lawrence Korducki; Maria Cristina De Salvo; Pierluigi Paggiaro
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-07-05

6.  Effect of tiotropium and olodaterol on symptoms and patient-reported outcomes in patients with COPD: results from four randomised, double-blind studies.

Authors:  Gary T Ferguson; Jill Karpel; Nathan Bennett; Emmanuelle Clerisme-Beaty; Lars Grönke; Florian Voß; Roland Buhl
Journal:  NPJ Prim Care Respir Med       Date:  2017-02-02       Impact factor: 2.871

7.  The Manchester Respiratory Activities of Daily Living Questionnaire: Reliability and Validity of the Chinese Version with Pictorial Enhancement.

Authors:  Damian Chi Hong Siu; Chi Tao So; Cherry Wai Lee Lau; Eric Hei Man Hui; Alexandra Fung; Tak Ming Chan; Fion Siu Fun Chan; Catherine Kam Fung Chan; William Pang Wai Chen; Sammy Hoo Ming Cheung; Katherine Pui Yee Chan; Peter Poon; Michael Cheung; Cherry Chan; Justin Tse; Vanessa Fung; Kenneth N K Fong
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-01-15

8.  Gender Differences in Chronic Obstructive Pulmonary Disease Symptom Clusters.

Authors:  Haihong Zhang; Fang Wu; Hongli Yi; Dongjuan Xu; Nana Jiang; Yonghong Li; Ming Li; Kefang Wang
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-04-20

9.  Adiposity increases weight-bearing exercise-induced dyspnea despite favoring resting lung hyperinflation in COPD.

Authors:  Zewari S; van den Borst B; van den Elshout Fj; Vercoulen Jh; Dekhuijzen Pn; Heijdra Yf; Vos Pj
Journal:  Chron Respir Dis       Date:  2022 Jan-Dec       Impact factor: 2.444

10.  Proposing a standardized method for evaluating patient report of the intensity of dyspnea during exercise testing in COPD.

Authors:  Asha Hareendran; Nancy K Leidy; Brigitta U Monz; Randall Winnette; Karin Becker; Donald A Mahler
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-05-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.